Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/02/2772079/0/en/Blue-Water-Biotech-Signs-Non-Binding-Term-Sheet-to-Acquire-a-Commercial-Stage-Oncology-Company.html

CINCINNATI, Nov. 02, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (Nasdaq:BWV) (“BWB” or the “Company”), today announced the execution of a non-binding term sheet regarding the acquisition of a private commercial stage oncology biotechnology company (the “Proposed Transaction”). This latest announcement is part of the Company’s new business strategy focusing on oncology. The Company plans to commercialize therapeutics, diagnostics and clinician services, which will serve as the foundation for the Company’s future operations.

Read more at globenewswire.com

Related news for (BWV)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.